Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 1
1971 1
1975 1
1976 2
1977 3
1978 3
1979 1
1980 5
1981 6
1982 10
1983 6
1984 5
1985 7
1986 8
1987 6
1988 4
1989 5
1990 9
1991 12
1992 7
1993 7
1994 9
1995 9
1996 13
1997 5
1998 13
1999 15
2000 19
2001 20
2002 17
2003 15
2004 30
2005 36
2006 29
2007 39
2008 47
2009 50
2010 57
2011 59
2012 67
2013 45
2014 81
2015 66
2016 59
2017 61
2018 76
2019 78
2020 96
2021 117
2022 104
2023 101
2024 93
2025 91
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,550 results

Results by year

Filters applied: . Clear all
Page 1
Momordica charantia L.-derived exosome-like nanovesicles stabilize p62 expression to ameliorate doxorubicin cardiotoxicity.
Ye C, Yan C, Bian SJ, Li XR, Li Y, Wang KX, Zhu YH, Wang L, Wang YC, Wang YY, Li TS, Qi SH, Luo L. Ye C, et al. J Nanobiotechnology. 2024 Aug 2;22(1):464. doi: 10.1186/s12951-024-02705-z. J Nanobiotechnology. 2024. PMID: 39095755 Free PMC article.
Here, we investigated the protective effects in DOX cardiotoxicity of ELNs from Momordica charantia L. (MC-ELNs), a medicinal plant with antioxidant activity. RESULTS: We isolated MC-ELNs using ultracentrifugation and characterized them with canonical mammalian extr …
Here, we investigated the protective effects in DOX cardiotoxicity of ELNs from Momordica charantia L. (MC-ELNs), a medicinal …
Antioxidant activity of Momordica charantia polysaccharide and its derivatives.
Chen F, Huang G, Yang Z, Hou Y. Chen F, et al. Int J Biol Macromol. 2019 Oct 1;138:673-680. doi: 10.1016/j.ijbiomac.2019.07.129. Epub 2019 Jul 22. Int J Biol Macromol. 2019. PMID: 31344411
Momordica charantia polysaccharide (MCP) was extracted by hot water and chemically modified to obtain phosphorylated Momordica charantia polysaccharide (P-MCP) with degree of substitution 0.12 and sulfated Momordica charantia polysacchari …
Momordica charantia polysaccharide (MCP) was extracted by hot water and chemically modified to obtain phosphorylated Momord …
Momordica charantia: a popular health-promoting vegetable with multifunctionality.
Wang S, Li Z, Yang G, Ho CT, Li S. Wang S, et al. Food Funct. 2017 May 24;8(5):1749-1762. doi: 10.1039/c6fo01812b. Food Funct. 2017. PMID: 28474032 Review.
Products derived from edible medicinal plants have been used for centuries to prevent, treat, and even cure multiple diseases. Momordica charantia L., widely cultivated around the world, is a typical one bred for vegetables and medicinal usage. ...In this review, we …
Products derived from edible medicinal plants have been used for centuries to prevent, treat, and even cure multiple diseases. Momordica …
Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents.
Xu B, Li Z, Zeng T, Zhan J, Wang S, Ho CT, Li S. Xu B, et al. Molecules. 2022 Mar 28;27(7):2175. doi: 10.3390/molecules27072175. Molecules. 2022. PMID: 35408574 Free PMC article. Review.
Momordica charantia L., a member of the Curcubitaceae family, has traditionally been used as herbal medicine and as a vegetable. ...Moreover, the clinical application of M. charantia in treating diabetes mellitus is also discussed, hoping to broaden the appli …
Momordica charantia L., a member of the Curcubitaceae family, has traditionally been used as herbal medicine and as a vegetabl …
Momordica charantia Bioactive Components: Hypoglycemic and Hypolipidemic Benefits Through Gut Health Modulation.
Xiao X, Huang S, Yang Z, Zhu Y, Zhu L, Zhao Y, Bai J, Kim KH. Xiao X, et al. J Med Food. 2024 Jul;27(7):589-600. doi: 10.1089/jmf.2024.k.0037. Epub 2024 May 21. J Med Food. 2024. PMID: 38770678 Review.
Momordica charantia (MC), a member of the Cucurbitaceae family, is well known for its pharmacological activities that exhibit hypoglycemic and hypolipidemic properties. ...
Momordica charantia (MC), a member of the Cucurbitaceae family, is well known for its pharmacological activities that exhibit …
Momordica Charantia: A Review of Its Effects on Metabolic Diseases and Mechanisms of Action.
Cortez-Navarrete M, Méndez-Del Villar M, Ramos-González EJ, Pérez-Rubio KG. Cortez-Navarrete M, et al. J Med Food. 2021 Oct;24(10):1017-1027. doi: 10.1089/jmf.2020.0206. Epub 2021 Mar 17. J Med Food. 2021. PMID: 33733863 Review.
The search for safe and effective complementary and alternative therapies to treat metabolic disorders is a key field of research. Momordica charantia (MC) is a tropical and subtropical vine of the Cucurbitaceae family used as a medicinal plant since ancient times. …
The search for safe and effective complementary and alternative therapies to treat metabolic disorders is a key field of research. Momord …
The Role of Momordica charantia in Resisting Obesity.
Fan M, Kim EK, Choi YJ, Tang Y, Moon SH. Fan M, et al. Int J Environ Res Public Health. 2019 Sep 4;16(18):3251. doi: 10.3390/ijerph16183251. Int J Environ Res Public Health. 2019. PMID: 31487939 Free PMC article. Review.
Momordica charantia (M. charantia), commonly known as bitter gourd, bitter melon, kugua, balsam pear, or karela, is a tropical and sub-tropical vine belonging to the Cucurbitaceae family. ...An advanced search was conducted on the worldwide accepted scientifi …
Momordica charantia (M. charantia), commonly known as bitter gourd, bitter melon, kugua, balsam pear, or karela, is a t …
Recent Advances in Momordica charantia: Functional Components and Biological Activities.
Jia S, Shen M, Zhang F, Xie J. Jia S, et al. Int J Mol Sci. 2017 Nov 28;18(12):2555. doi: 10.3390/ijms18122555. Int J Mol Sci. 2017. PMID: 29182587 Free PMC article. Review.
Momordica charantia L. (M. charantia), a member of the Cucurbitaceae family, is widely distributed in tropical and subtropical regions of the world. ...However, both in vitro and in vivo studies have also demonstrated that M. charantia may also exert t …
Momordica charantia L. (M. charantia), a member of the Cucurbitaceae family, is widely distributed in tropical and subt …
Momordica charantia reverses type II diabetes in rat.
Malekshahi H, Bahrami G, Miraghaee S, Ahmadi SA, Sajadimajd S, Hatami R, Mohammadi B, Keshavarzi S. Malekshahi H, et al. J Food Biochem. 2019 Nov;43(11):e13021. doi: 10.1111/jfbc.13021. Epub 2019 Aug 23. J Food Biochem. 2019. PMID: 31441956
Recently, scientists have been exploring a promising treatment of diabetes involving herbal medicine. In this line, we show that Momordica charantia, a tendril-bearing vine belonging to the Cucurbitaceae family, permanently normalizes blood glucose levels comparable …
Recently, scientists have been exploring a promising treatment of diabetes involving herbal medicine. In this line, we show that Momordic …
Momordica charantia for type 2 diabetes mellitus.
Ooi CP, Yassin Z, Hamid TA. Ooi CP, et al. Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD007845. doi: 10.1002/14651858.CD007845.pub3. Cochrane Database Syst Rev. 2012. PMID: 22895968 Free PMC article.
BACKGROUND: Momordica charantia (bitter gourd) is not only a nutritious vegetable but it is also used in traditional medical practices to treat type 2 diabetes mellitus. ...There was no statistically significant difference in the glycaemic control with momordica …
BACKGROUND: Momordica charantia (bitter gourd) is not only a nutritious vegetable but it is also used in traditional medical p …
1,550 results